Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease
Status:
Completed
Trial end date:
2015-09-23
Target enrollment:
Participant gender:
Summary
The primary objective of the study was to evaluate the safety and tolerability of cinacalcet
after a single oral dose in children aged 28 days to less than 6 years with chronic kidney
disease receiving dialysis.